10:33 AM EST - Fennec Pharmaceuticals Inc. : Will release its full year and fourth quarter 2025 financial results before the opening of the U.S. financial markets on Tuesday, March 24. Fennec Pharmaceuticals Inc.
shares T.FRX are trading down $0.01 at $10.72.
